Difference between revisions of "Heracleia"
(Created page with "Heracleia is a non-scientific common name that may refer to a number of plant species and varieties. == Nomenclature== === Other Names:=== == Historical Use of Heracleia== ===...") |
(Added Western Medicine category) |
||
| Line 31: | Line 31: | ||
===Pregnancy and Breastfeeding=== | ===Pregnancy and Breastfeeding=== | ||
===Adverse Effects=== | ===Adverse Effects=== | ||
| + | [[Category:Western Medicine]] | ||
Revision as of 11:53, 8 April 2015
Heracleia is a non-scientific common name that may refer to a number of plant species and varieties.
Contents
Nomenclature
Other Names:
Historical Use of Heracleia
Heracleia in Traditional Chinese Medicine
Description
Historical Use of Heracleia in Western Medicine
Quote Paraph: "Frothy poppy acts as a 'specific' emetic for epilepsy; the 'frothy' structure of the plant could have served as a signature, associating it with the well-known frothing of the epileptic, and its other name of 'heracleia' connects it with the disease of Heracles."
Sec Auth: Temkin O
Title: The Falling Sickness. Second Edition, Revised, Softshell Books edition, 1994
Page: 80
Source: The Falling Sickness, Second Edition, Revised, Softshell Books edition, 1994,Owsei Temkin
Complete: Temkin O. The falling sickness: a history of epilepsy from the Greeks to the beginnings of modern neurology. London: Johns Hopkins Univ. Press, 2 Revised Edition, (Softshell Books) ; 1994. p. 80.
Primary Source: 548 Cf. Dioscurides (282), ed. Wellmann, vol. 2, p.223, 12.
Background
Synonymns for Heracleia
Patent Medicines and Medicines with Multiple Ingredients that include Heracleia
Pharmaceutical Information
Chemical Constituents
Evidence or the Use of Heracleia in the Treatment of Epilepesy
Basic Science
Animal Studies
Cohort, Case-Control and Non-Randomized Trials
Randomized Controlled Trials
Meta-Analysis
1st Five Results: pubmed search
Huachun Huang, Dongying Huang, Cuimi Luo, Zhuoyan Qiu, Jinou Zheng
Abnormalities of regional brain activity and executive function in patients with temporal lobe epilepsy: A cross-sectional and longitudinal resting-state functional MRI study.
Neuroradiology: 2024;
[PubMed:38668803]
[WorldCat.org]
[DOI]
(I a)
N C D Fonseca, Jason Bowerman, Pegah Askari, Amy L Proskovec, Fabricio Stewan Feltrin, Daniel Veltkamp, Heather Early, Ben C Wagner, Elizabeth M Davenport, Joseph A Maldjian
Magnetoencephalography Atlas Viewer for Dipole Localization and Viewing.
J Imaging: 2024, 10(4);
[PubMed:38667978]
[WorldCat.org]
[DOI]
(I e)
Dawid M Zakrzewski, Patrycja Podlejska, Wiktoria Kubziakowska, Kamil Dzwilewski, Przemysław M Waszak, Marta Zawadzka, Maria Mazurkiewicz-Bełdzińska
Evaluating the Credibility and Reliability of Online Information on Cannabidiol (CBD) for Epilepsy Treatment in Poland.
Healthcare (Basel): 2024, 12(8);
[PubMed:38667591]
[WorldCat.org]
[DOI]
(P e)
Alexandre Brenet, Julie Somkhit, Zsolt Csaba, Sorana Ciura, Edor Kabashi, Constantin Yanicostas, Nadia Soussi-Yanicostas
Microglia Mitigate Neuronal Activation in a Zebrafish Model of Dravet Syndrome.
Cells: 2024, 13(8);
[PubMed:38667299]
[WorldCat.org]
[DOI]
(I e)
Hua Yang, Dongjie Zhang, Shifeng Wei, Zhigang Zhao, Shenghui Mei
Population Pharmacokinetics of Lamotrigine and Its N2-Glucuronide Metabolite in Chinese Patients with Epilepsy.
Ther Drug Monit: 2024;
[PubMed:38666475]
[WorldCat.org]
[DOI]
(I a)
